{
    "Trade/Device Name(s)": [
        "BinaxNOW\u00ae Legionella Urinary Antigen Test",
        "Binax NOW \u2297 Legionella Urinary Antigen Test",
        "Legionella ICT"
    ],
    "Submitter Information": "Binax, Inc. d/b/a Inverness Medical Professional Diagnostics",
    "510(k) Number": "K070522",
    "Predicate Device Reference 510(k) Number(s)": [
        "K982238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MJH"
    ],
    "Summary Letter Date": "February 14, 2007",
    "Summary Letter Received Date": "February 23, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3300"
    ],
    "Regulation Name(s)": [
        "Haemophilus spp. serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Legionella pneumophila serogroup 1 antigen"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic membrane assay",
        "Lateral flow immunochromatographic technology",
        "Immunoassay"
    ],
    "Methodologies": [
        ""
    ],
    "Submission Type(s)": [
        "Assay",
        "Test"
    ],
    "Document Summary": "FDA 510(k) summary for BinaxNOW Legionella Urinary Antigen rapid immunochromatographic assay for detection of L. pneumophila serogroup 1 antigen in urine",
    "Indications for Use Summary": "Qualitative detection of Legionella pneumophila serogroup 1 antigen in urine specimens from patients with symptoms of pneumonia to aid in presumptive diagnosis of Legionella infection (Legionnaires' disease) in conjunction with culture and other methods.",
    "fda_folder": "Microbiology"
}